ZOOMINFO CONVERSE LLC – Trademark Portfolio
Entity Type: 16
ZOOMINFO CONVERSE LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CHORUS, CLONE YOUR CLOSERS, and MAKE EVERY INTERACTION COUNT. The owner is based in VANCOUVER, WA.
805 BROADWAY ST., SUITE 900
VANCOUVER, WA 98660
Showing of trademarks Trademarks
Trademark Classifications
ZOOMINFO CONVERSE LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ZOOMINFO CONVERSE LLC have?
ZOOMINFO CONVERSE LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does ZOOMINFO CONVERSE LLC file in?
ZOOMINFO CONVERSE LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 37 (Building & Construction). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ZOOMINFO CONVERSE LLC's most well-known trademarks?
ZOOMINFO CONVERSE LLC's registered trademark portfolio includes well-known marks such as CHORUS, CLONE YOUR CLOSERS, and MAKE EVERY INTERACTION COUNT. These are among 4 currently registered trademarks in the portfolio.
What is ZOOMINFO CONVERSE LLC's trademark registration success rate?
ZOOMINFO CONVERSE LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.